Effect Inverse Ratio Ventilation on Arterial Oxygenation and Respiratory Mechanics During lapaLAR
Launched by GACHON UNIVERSITY GIL MEDICAL CENTER · Jul 9, 2013
Trial Information
Current as of August 21, 2025
Completed
Keywords
ClinConnect Summary
Inverse ratio ventilation already known as effective to improve the oxygenation and respiratory mechanics in the ARDS patients. Recently, there were report of decrease in airway pressure and improve in respiratory compliance during inverse ration ventilation undergoing one lung ventilation. We hypothesized that changes of inspiration and expiration ratio from 1:2 to 1:1 could improve the arterial oxygenation and respiratory mechanics in the patients who undergoing laparoscopic low anterior resection. However, prolonged inspiratory time might compromise cerebral perfusion pressure due to an ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • colorectal cancer
- Exclusion Criteria:
- • obesity (BMI\>35), uncontrolled hypertension, coronary artery disease, uncompensated cardiovascular disease, current respiratory disease, open procedure
About Gachon University Gil Medical Center
Gachon University Gil Medical Center is a leading healthcare institution located in South Korea, renowned for its commitment to advancing medical research and clinical excellence. As a prominent clinical trial sponsor, the center leverages its comprehensive expertise in various medical fields to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong focus on collaboration, Gachon University Gil Medical Center engages in partnerships with academic institutions, industry leaders, and healthcare professionals to drive the development of groundbreaking therapies and treatment modalities. Its state-of-the-art facilities and dedicated research teams ensure rigorous adherence to ethical standards and regulatory compliance, positioning the center at the forefront of clinical research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Incheon, , Korea, Republic Of
Patients applied
Trial Officials
Hyun Jeong Kwak, M.D., Ph.D
Study Director
Gachon University Gil Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials